BIT 6.82% 8.2¢ biotron limited

$10 Billion Deal, page-141

  1. 15,746 Posts.
    lightbulb Created with Sketch. 666
    "Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial "

    Can someone explain how they came to this conclusion in a short time frame after treatment based on 27 patients with half on placebo. The variability of data on such a small patient population looking at immune system ages and neurocognitive disorder is going to give you non conclusive data imo. Longer term data on over 300 patients in a phase 2b study can only give any significant results. IMO the reported results are a beat up to get the 6c options exercised.

    "These include an immune system ages more quickly, and there are other problems such as HIV-associated neurocognitive disorder (also known as AIDS-related dementia).
    Last edited by malmanu: 13/11/18
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Mkt cap ! $57.55M
Open High Low Value Volume
8.6¢ 8.6¢ 8.1¢ $153.8K 1.845M

Buyers (Bids)

No. Vol. Price($)
4 268178 8.2¢

Sellers (Offers)

Price($) Vol. No.
8.6¢ 23000 1
View Market Depth
Last trade - 15.59pm 21/01/2022 (20 minute delay) ?
-0.006 ( 4.60 %)
Open High Low Volume
8.5¢ 8.6¢ 8.1¢ 613971
Last updated 15.54pm 21/01/2022 (live) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.